01 Communique Provides an Update on its Patent Litigation with LogMeIn Inc. TORONTO, Jan. 18, 2013 /CNW/ - 01 Communique (TSX:ONE) today provided an update on its patent litigation against LogMeIn Inc. with a trial set to commence Monday March 18, 2013. At the pretrial conference held yesterday a court date was set for March 18, 2013. In addition, there were two hearings that took place today, Friday January 18, 2013. The Company's renewed motion for summary judgment on the issue pertaining to inequitable conduct was denied and LogMeIn's motion to dismiss the case for failure to join an indispensable party was also denied. "We remain confident in the merits of our case," said Andrew Cheung, President and CEO for 01 Communique. "We are preparing in earnest for trial and look forward to our day in court which is only 2 months away." The Toronto Stock Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release. About 01 Communique Established in 1992, 01 Communique Laboratory Inc. (TSX: ONE) offers a suite of remote access services designed for small-medium sized business, mobile professionals and IT service providers. 01's software as a service offerings are deployed on-demand and include functionality enabling on-line meetings, remote computing and IT support. 01's suite of products includes its remote access offering I'm InTouch (www.imintouch.com), its online meeting offering (www.imintouchmeeting.com) and its remote support offering I'm OnCall (www.imoncall.com ) products are protected in the U.S.A. by its patents #6928479 / #6938076 / #8234701 and in Canada by its patent #2309398 and Japan by its patent #4,875,094. For more information, visit www.01com.com or call (905) 795-888 or (800) 668-2185 (North America only). Cautionary Note Regarding Forward-looking Statements. Certain statements in this news release may constitute "forward-looking" statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this news release, such statements use such words as "may", "will", "expect", "believe", "plan", "intend", "are confident" and other similar terminology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this news release. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under "Risk Factors" in the Company's Annual Information Form filed on SEDAR, which include the risks associated with its litigation against Citrix and LogMeIn. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward looking statements. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances. INVESTOR CONTACT: Brian Stringer Chief Financial Officer 01 Communique (905) 795-2888 x204 email@example.com SOURCE: 01 Communique Laboratory Inc. To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/January2013/18/c7011.html CO: 01 Communique Laboratory Inc. ST: Ontario NI: CPR ELE SOF LAW VERDICTS LAWVIEWS -0- Jan/18/2013 16:29 GMT
01 Communique Provides an Update on its Patent Litigation with LogMeIn Inc.
Press spacebar to pause and continue. Press esc to stop.